(NASDAQ: AXDX) Accelerate Diagnostics's forecast annual revenue growth rate of 0.91% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.87%.
Accelerate Diagnostics's revenue in 2024 is $12,059,000.On average, 1 Wall Street analysts forecast AXDX's revenue for 2024 to be $263,633,925, with the lowest AXDX revenue forecast at $263,633,925, and the highest AXDX revenue forecast at $263,633,925.
In 2025, AXDX is forecast to generate $313,721,988 in revenue, with the lowest revenue forecast at $313,721,988 and the highest revenue forecast at $313,721,988.